151 related articles for article (PubMed ID: 36480186)
21. The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.
Bogerd HP; Wiegand HL; Doehle BP; Cullen BR
Virology; 2007 Aug; 364(2):486-93. PubMed ID: 17434555
[TBL] [Abstract][Full Text] [Related]
22. APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis.
Sadler HA; Stenglein MD; Harris RS; Mansky LM
J Virol; 2010 Jul; 84(14):7396-404. PubMed ID: 20463080
[TBL] [Abstract][Full Text] [Related]
23. APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.
Lindley RA; Hall NE
Mutat Res; 2018 Jul; 810():33-38. PubMed ID: 29957488
[TBL] [Abstract][Full Text] [Related]
24. Inhibiting APOBEC3 Activity with Single-Stranded DNA Containing 2'-Deoxyzebularine Analogues.
Kvach MV; Barzak FM; Harjes S; Schares HAM; Jameson GB; Ayoub AM; Moorthy R; Aihara H; Harris RS; Filichev VV; Harki DA; Harjes E
Biochemistry; 2019 Feb; 58(5):391-400. PubMed ID: 30418757
[TBL] [Abstract][Full Text] [Related]
25. Signatures of mutational processes in human cancer.
Alexandrov LB; Nik-Zainal S; Wedge DC; Aparicio SA; Behjati S; Biankin AV; Bignell GR; Bolli N; Borg A; Børresen-Dale AL; Boyault S; Burkhardt B; Butler AP; Caldas C; Davies HR; Desmedt C; Eils R; Eyfjörd JE; Foekens JA; Greaves M; Hosoda F; Hutter B; Ilicic T; Imbeaud S; Imielinski M; Jäger N; Jones DT; Jones D; Knappskog S; Kool M; Lakhani SR; López-Otín C; Martin S; Munshi NC; Nakamura H; Northcott PA; Pajic M; Papaemmanuil E; Paradiso A; Pearson JV; Puente XS; Raine K; Ramakrishna M; Richardson AL; Richter J; Rosenstiel P; Schlesner M; Schumacher TN; Span PN; Teague JW; Totoki Y; Tutt AN; Valdés-Mas R; van Buuren MM; van 't Veer L; Vincent-Salomon A; Waddell N; Yates LR; ; ; ; ; Zucman-Rossi J; Futreal PA; McDermott U; Lichter P; Meyerson M; Grimmond SM; Siebert R; Campo E; Shibata T; Pfister SM; Campbell PJ; Stratton MR
Nature; 2013 Aug; 500(7463):415-21. PubMed ID: 23945592
[TBL] [Abstract][Full Text] [Related]
26. Functional central polypurine tract provides downstream protection of the human immunodeficiency virus type 1 genome from editing by APOBEC3G and APOBEC3B.
Wurtzer S; Goubard A; Mammano F; Saragosti S; Lecossier D; Hance AJ; Clavel F
J Virol; 2006 Apr; 80(7):3679-83. PubMed ID: 16537639
[TBL] [Abstract][Full Text] [Related]
27. Differential Inhibition of APOBEC3 DNA-Mutator Isozymes by Fluoro- and Non-Fluoro-Substituted 2'-Deoxyzebularine Embedded in Single-Stranded DNA.
Kvach MV; Barzak FM; Harjes S; Schares HAM; Kurup HM; Jones KF; Sutton L; Donahue J; D'Aquila RT; Jameson GB; Harki DA; Krause KL; Harjes E; Filichev VV
Chembiochem; 2020 Apr; 21(7):1028-1035. PubMed ID: 31633265
[TBL] [Abstract][Full Text] [Related]
28. In Vivo Examination of Mouse APOBEC3- and Human APOBEC3A- and APOBEC3G-Mediated Restriction of Parvovirus and Herpesvirus Infection in Mouse Models.
Nakaya Y; Stavrou S; Blouch K; Tattersall P; Ross SR
J Virol; 2016 Sep; 90(17):8005-12. PubMed ID: 27356895
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.
Bonvin M; Greeve J
Curr Opin Infect Dis; 2008 Jun; 21(3):298-303. PubMed ID: 18448976
[TBL] [Abstract][Full Text] [Related]
30. APOBEC3G protects the genome of human cultured cells and mice from radiation-induced damage.
Britan-Rosich Y; Ma J; Kotler E; Hassan F; Botvinnik A; Smith Y; Moshel O; Nasereddin A; Sharma G; Pikarsky E; Ross S; Kotler M
FEBS J; 2023 Apr; 290(7):1822-1839. PubMed ID: 36325681
[TBL] [Abstract][Full Text] [Related]
31. Different mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanisms.
Ara A; Love RP; Chelico L
PLoS Pathog; 2014 Mar; 10(3):e1004024. PubMed ID: 24651717
[TBL] [Abstract][Full Text] [Related]
32. Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.
Armitage AE; Deforche K; Welch JJ; Van Laethem K; Camacho R; Rambaut A; Iversen AK
J Virol; 2014 Nov; 88(21):12882-94. PubMed ID: 25165112
[TBL] [Abstract][Full Text] [Related]
33. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
[TBL] [Abstract][Full Text] [Related]
34. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population.
Ezzikouri S; Kitab B; Rebbani K; Marchio A; Wain-Hobson S; Dejean A; Vartanian JP; Pineau P; Benjelloun S
J Viral Hepat; 2013 Oct; 20(10):678-86. PubMed ID: 24010642
[TBL] [Abstract][Full Text] [Related]
35. Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer.
Baker SC; Mason AS; Slip RG; Skinner KT; Macdonald A; Masood O; Harris RS; Fenton TR; Periyasamy M; Ali S; Southgate J
Oncogene; 2022 Apr; 41(15):2139-2151. PubMed ID: 35194151
[TBL] [Abstract][Full Text] [Related]
36. Clustered mutations in hominid genome evolution are consistent with APOBEC3G enzymatic activity.
Pinto Y; Gabay O; Arbiza L; Sams AJ; Keinan A; Levanon EY
Genome Res; 2016 May; 26(5):579-87. PubMed ID: 27056836
[TBL] [Abstract][Full Text] [Related]
37. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis.
Taylor BJ; Nik-Zainal S; Wu YL; Stebbings LA; Raine K; Campbell PJ; Rada C; Stratton MR; Neuberger MS
Elife; 2013 Apr; 2():e00534. PubMed ID: 23599896
[TBL] [Abstract][Full Text] [Related]
38. Human APOBEC3G Prevents Emergence of Infectious Endogenous Retrovirus in Mice.
Treger RS; Tokuyama M; Dong H; Salas-Briceno K; Ross SR; Kong Y; Iwasaki A
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341050
[TBL] [Abstract][Full Text] [Related]
39. APOBEC mediated mutagenesis drives genomic heterogeneity in endometriosis.
Revathidevi S; Nakaoka H; Suda K; Fujito N; Munirajan AK; Yoshihara K; Enomoto T; Inoue I
J Hum Genet; 2022 Jun; 67(6):323-329. PubMed ID: 35017684
[TBL] [Abstract][Full Text] [Related]
40. The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction.
Schumacher AJ; Haché G; Macduff DA; Brown WL; Harris RS
J Virol; 2008 Mar; 82(6):2652-60. PubMed ID: 18184715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
